<?xml version="1.0" encoding="UTF-8"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://jcp.bmj.com">
<title>Journal of Clinical Pathology Snippets in pathology</title>
<link>http://jcp.bmj.com</link>
<description>Journal of Clinical Pathology RSS feed -- recent Snippets in pathology articles</description>
<prism:publicationName>Journal of Clinical Pathology</prism:publicationName>
<prism:issn>0021-9746</prism:issn>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://jcp.bmj.com/cgi/content/short/64/5/451?rss=1" />
 </rdf:Seq>
</items>
<image rdf:resource="http://hwmaint.jcp.bmj.com/homepage/JCP_95x60.gif" />
</channel>

<image rdf:about="http://hwmaint.jcp.bmj.com/homepage/JCP_95x60.gif">
<title>Journal of Clinical Pathology</title>
<url>http://hwmaint.jcp.bmj.com/homepage/JCP_95x60.gif</url>
<link>http://jcp.bmj.com</link>
</image>

<item rdf:about="http://jcp.bmj.com/cgi/content/short/64/5/451?rss=1">
<title><![CDATA[Snippets in haematology]]></title>
<link>http://jcp.bmj.com/cgi/content/short/64/5/451?rss=1</link>
<description><![CDATA[ <sec><st><I>British Journal of Haematology</I></st><sec><st>July 2010</st> <p><b>Berenson JR</b>, Anderson KC, Audell RA, <I>et al</I>. Monoclonal gammopathy of undetermined significance: a consensus statement. <I>Br J Haematol</I> 2010;<b>150</b>:28&ndash;38.</p> <p>Paraproteins are common in the elderly population and less than 1% per year will transform to a more serious B cell malignancy. In light of the low transformation rate, afflicted patients do not need to be referred to a haematologist. Rather, this guideline provides advice on the diagnosis, staging and follow-up of monoclonal gammopathy of undetermined significance, and raises awareness of the associated problems of peripheral neuropathy, thromboembolic disease and osteoporosis.</p> <p><b>Coiffier B</b>, Losic N, Ronn BB, <I>et al</I>. Pharmacokinetics and pharmacokinetic/pharmacodynamic associations of ofatumumab, a human monoclonal CD20 antibody, in patients with relapsed or refractory chronic lymphocytic leukaemia: a phase 1&ndash;2 study. <I>Br J Haematol</I> 2010;<b>150</b>:58&ndash;71.</p> <p>Rituximab is a monoclonal antibody to the CD20 transmembrane protein, and it has significantly improved outcomes in...]]></description>
<dc:creator><![CDATA[McCloskey, S., McMullin, M. F.]]></dc:creator>
<dc:date>2011-04-20T16:41:52-07:00</dc:date>
<dc:subject><![CDATA[Pancreas and biliary tract, Molecular genetics, Immunology (including allergy), Breast cancer, Colon cancer, Musculoskeletal syndromes, Osteoporosis]]></dc:subject>
<dc:identifier>info:doi/10.1136/jclinpath-2011-200031</dc:identifier>
<dc:title><![CDATA[Snippets in haematology]]></dc:title>
<dc:publisher>BMJ Publishing Group</dc:publisher>
<prism:publicationDate>2011-05-01</prism:publicationDate>
<prism:section>Snippets in pathology</prism:section>
<prism:volume>64</prism:volume>
<prism:number>5</prism:number>
<prism:startingPage>451</prism:startingPage>
<prism:endingPage>455</prism:endingPage>
</item>

</rdf:RDF>